Work

Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone

Year: 2006

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdl315

Authors: S. Mani, H.M. McDaid, A. Grossman, F. Muggia, S. Goel, T. Griffin, D. Colevas, S.B. Horwitz, M.J. Egorin

Institutions: Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, New York University, Bristol-Myers Squibb (United States), National Institutes of Health, National Cancer Institute, UPMC Hillman Cancer Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Susan G. Komen for the Cure, Damon Runyon Cancer Research Foundation, Yeshiva University, Deutsches Krebsforschungszentrum, National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: G1553362528, G16560278, Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm, PHASE I STUDIES OF ANTICANCER DRUG AND GENE THERAPY, GENERAL CLINICAL RESEARCH CENTER M01 RR12248, TRANSLATIONAL CORRELATES OF AN EPOTHILONE B ANALOG, G3578179653, ANTITUMOR DRUGS--MECHANISMS OF ACTION AND RESISTANCE, G5797786972, General Clinical Research Center, G7194230002, Cancer Center Support Grant

OpenAlex ID: W2105784574

FWCI: 2.08

Cites: 22

Cited by: 20

Related to: 10